Growth potential Mid-sized OTC solid dosage manufacturer with a track record since 1987 presenting a target for contract manufacturing, private label, and line extension partnerships to expand production capacity and product portfolio.

Quality emphasis Strong cGMP and GLP adherence highlighted by leadership with advanced degrees, offering a compelling value proposition for partners seeking compliant, high-quality manufacturing and rigorous testing capabilities.

Geographic edge Based in New York with a regional footprint that can support US-based distribution, regulatory alignment, and accelerated time-to-market for domestic OTC products and generics.

Tech enablement Utilizes modern website and CMS tools, suggesting openness to digital collaboration, customer portals, and streamlined RFP/quoting processes that can improve sales efficiency.

Financial signal Revenue in the low-to-mid single-digit millions indicates sizable production capacity yet potential for scalable partnerships with larger distributors or brands seeking reliable manufacturers for OTC portfolios.